1-3 of 3
Yelena Usachenko
Close
Sort by
Journal Articles

Constitutive Expression of CD40L by CAR-Modified Tumor Targeted T Cells Enhances Anti-Tumor Efficacy Both in Vitro and in Vivo

Kevin J. Curran, MD, Beatrijs Seinstra, MD, Yan Nikhamin, MS, MBA, Raymond Yeh, PhD, Yelena Usachenko, BS, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4120.
https://doi.org/10.1182/blood.V120.21.4120.4120
Published: 2012
Journal Articles

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Clinical Trials & Observations
Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Marco L. Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda, Malgorzata Olszewska, Yvette Bernal, Hollie Pegram, Mark Przybylowski, Daniel Hollyman, Yelena Usachenko, Domenick Pirraglia, James Hosey, Elmer Santos, Elizabeth Halton, Peter Maslak, David Scheinberg, Joseph Jurcic, Mark Heaney, Glenn Heller, Mark Frattini, Michel Sadelain
Journal: Blood
Blood (2011) 118 (18): 4817–4828.
https://doi.org/10.1182/blood-2011-04-348540
Published: 2011
Includes: Supplemental data
Journal Articles

Genetic Correction of Sickle Cell Disease by Co-Regulated γ-Globin Transgene Expression and ßS Interference.

Selda Samakoglu, Yelena Usachenko, Tulin Budak-Alpdogan, Santina Acuto, Rosalba DiMarzo, Aurelio Maggio, John Tisdale, Isabelle Riviere, Michel Sadelain
Journal: Blood
Blood (2005) 106 (11): 1280.
https://doi.org/10.1182/blood.V106.11.1280.1280
Published: 2005